Frontiers Safety and therapeutic effects of personalized

PRIME® Continuing Medical Education

A Decade On: The Evolving Renaissance in Intracranial Atherosclerotic Disease

Frontiers Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis - The Lancet Microbe

Drug-microbiota interactions: an emerging priority for precision medicine

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study - eClinicalMedicine

SPECIAL FEATURE - Injection Devices: Three Trends Influencing Development & Delivery

Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial - The Lancet Oncology

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis: Molecular Therapy - Methods & Clinical Development

Insight into Personalized Vaccines